Treatment of ovarian cancer with surgery, short-course chemotherapy and whole abdominal radiation

Annals of Oncology

Volumn 7, Issue 1, 1996, Pages 65-70

  Buser, K ^a   Bacchi, M ^b   Goldhirsch, A ^c   Greiner, R ^a   Diener, P ^d   Sessa, C ^e   Jungi, W F ^f   Forni, M ^g   Leyvraz, S ^h   Engeler, V ⁱ  

^a UNIVERSITY OF BERN   (Switzerland)

^b SIAK Coordinating Center   (Switzerland)

^c Ospedale Civico Lugano   (Switzerland)

^d Pathologisches Institut   (Switzerland)

^e OSPEDALE SAN GIOVANNI   (Switzerland)

^f CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^g Hôpital Universitaire HUG   (Switzerland)

^h LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁱ Universitätsfrauenklinik   (Switzerland)

Author keywords

Advanced ovarian cancer; Chemotherapy; Cisplatin; Melphalan; Second look surgery; Whole abdominal radiation

Indexed keywords

CISPLATIN; MELPHALAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 13344286368     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010481     Document Type: Article

References (20)

1. Neijt JP. ten Bokkel Huinink WW. van der Burg MEL et al. Long-term survival in ovarian cancer. Mature Data from the Netherlands Joint Study Group for Ovarian Cancer. Eur J Cancer 1991; 27: 1367-72.
2. Piver MS, Malfetano J, Baker TR et al. Five-year survival for stage IC or stage I grade III epithelial ovarian cancer treated with cisplatin-based chemotherapy. Gynecol Oncol 1992; 46: 357-60.
3. Swenerton K, Jeffrey J, Stuart G et al. Cisplatinum-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: A randomized phase II study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1992; 10: 718-26.
4. Goldhirsch A, Greiner R. Dreher E et al. Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy. Cancer 1988; 62: 40-7.
5. Dembo AJ, Bush RS, Beale FA et al. Ovarian carcinoma: Improved survival following abdomino-pelvic irradiation in patients with completed pelvic operation. Am J Obstet Gynecol 1979; 134: 793-800.
6. Dembo AJ, Bush RS, Beale FA et al. A randomized clinical trial of moving strip versus open-field whole-abdominal irradiation in patients with invasive epithelial cancer of the ovary. Int J Radiat Oncol Biol Phys 1983; 9 (Suppl 1): 97.
7. Cain JM, Russell AH, Greer BE et al. Whole-abdomen radiation for minimal residual epithelial ovarian carcinoma after surgical resection and maximal first-line chemotherapy. Gynecol Oncol 1988; 29: 168-75.
8. Rothenberg ML, Ozols RF, Glatstein E, et al. Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancer. J Clin Oncol 1992; 10: 727-34.
9. WHO Handbook for Reporting Results of Cancer Treatment. Geneva: World Health Organization 1979.
10. Kaplan EL. Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass 1958; 53: 457-81.
11. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1-39.
12. Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
13. Berthelsen K, Jacobsen I, Troyer KN et al. A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin and cisplatin in advanced epithelial ovarian cancer: A Danish Ovarian Study Group (DACOVA). Gynecol Oncol 1993; 49: 30-6.
14. Hainsworth JD, Grosh WW, Burnett LS et al. Advanced ovarian cancer: Long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration. Ann Int Med 1988; 108: 165-70.
15. Omura G, Buny B, Berek J. Randomized trial of cyclophosphamide plus cisplatinum with or without doxorubicin in ovarian carcinoma. A Gynaecologic Oncology Group study. J Clin Oncol 1989; 7: 457-65.
16. Levin L, Lund B, Heintz APM. An overview of multivariate analyses of prognostic variables with special reference to the role of cytoreductive surgery. Ann Oncol 1993; 4 (Suppl 4): 23-9.
17. Franchin G, Tumolo S, Scarabelli C et al. Whole-abdomen radiation therapy after short-term chemotherapy course and second-look laparotomy in advanced ovarian cancer. Gynecol Oncol 1991; 41: 206-11.
18. Kucera PR, Berman ML, Treadwell P et al. Whole-abdominal radiotherapy for patients with minimal residual epithelial ovarian cancer. Gynecol Oncol 1990; 36: 338-42.
19. Lambert HE, Rustin GJS, Gregory WM et al. A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: A North Thames Ovary Group Study. J Clin Oncol 1993; 11: 440-8.
20. Thomas GM. Is there a role for consolidation or salvage radiotherapy after chemotherapy in advanced epithelial ovarian cancer? Gynecol Oncol 1993; 51: 97-103.